Alex joined the Clinical Trials Service Unit (CTSU) as part of the China Kadoorie Biobank research group in October 2023 as a DPhil student in Population Health. Prior to this, Alex completed the MSc in Global Health Science and Epidemiology at the University of Oxford in 2023, and a BSc in Biomedical Sciences with Industrial Experience at the University of Reading in 2022. During his undergraduate, he spent a year working on various phase 4 vaccine trials across Europe and the United States as part of the Medical Development Scientific/Clinical Affairs (MDSCA) department at Pfizer.
His current research uses proteomic analysis to elucidate causal mechanisms of long-term cardiovascular disease health risks associated with adiposity in diverse populations, using both the China Kadoorie and UK biobanks. Alex is supervised by Dr Fiona Bragg, Dr Andri Iona, and Professor Zhengming Chen. In his spare time, Alex enjoys reading about 19th-century European history and following sports such as football, rugby, and powerlifting.